616 related articles for article (PubMed ID: 35107767)
1. Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.
Barak M; Fedorova V; Pospisilova V; Raska J; Vochyanova S; Sedmik J; Hribkova H; Klimova H; Vanova T; Bohaciakova D
Stem Cell Rev Rep; 2022 Feb; 18(2):792-820. PubMed ID: 35107767
[TBL] [Abstract][Full Text] [Related]
2. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
[TBL] [Abstract][Full Text] [Related]
3. Cerebral organoids derived from patients with Alzheimer's disease with PSEN1/2 mutations have defective tissue patterning and altered development.
Vanova T; Sedmik J; Raska J; Amruz Cerna K; Taus P; Pospisilova V; Nezvedova M; Fedorova V; Kadakova S; Klimova H; Capandova M; Orviska P; Fojtik P; Bartova S; Plevova K; Spacil Z; Hribkova H; Bohaciakova D
Cell Rep; 2023 Nov; 42(11):113310. PubMed ID: 37864790
[TBL] [Abstract][Full Text] [Related]
4. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
Sahlgren Bendtsen KM; Hall VJ
Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
[TBL] [Abstract][Full Text] [Related]
5. REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer's Disease.
Meyer K; Feldman HM; Lu T; Drake D; Lim ET; Ling KH; Bishop NA; Pan Y; Seo J; Lin YT; Su SC; Church GM; Tsai LH; Yankner BA
Cell Rep; 2019 Jan; 26(5):1112-1127.e9. PubMed ID: 30699343
[TBL] [Abstract][Full Text] [Related]
6. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
Young JE; Goldstein LSB
Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
[TBL] [Abstract][Full Text] [Related]
7. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
Fan W; Sun Y; Shi Z; Wang H; Deng J
Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
[TBL] [Abstract][Full Text] [Related]
8. Stem cell models of Alzheimer's disease: progress and challenges.
Arber C; Lovejoy C; Wray S
Alzheimers Res Ther; 2017 Jun; 9(1):42. PubMed ID: 28610595
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?
Rodriguez-Jimenez FJ; Ureña-Peralta J; Jendelova P; Erceg S
J Adv Res; 2023 Dec; 54():105-118. PubMed ID: 36646419
[TBL] [Abstract][Full Text] [Related]
10. Modeling amyloid beta and tau pathology in human cerebral organoids.
Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
[TBL] [Abstract][Full Text] [Related]
11. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure.
Chen X; Sun G; Tian E; Zhang M; Davtyan H; Beach TG; Reiman EM; Blurton-Jones M; Holtzman DM; Shi Y
Adv Sci (Weinh); 2021 Sep; 8(18):e2101462. PubMed ID: 34337898
[TBL] [Abstract][Full Text] [Related]
12. Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research.
Bi FC; Yang XH; Cheng XY; Deng WB; Guo XL; Yang H; Wang Y; Li J; Yao Y
Transl Neurodegener; 2021 Aug; 10(1):27. PubMed ID: 34372927
[TBL] [Abstract][Full Text] [Related]
13. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
14. Culture Variabilities of Human iPSC-Derived Cerebral Organoids Are a Major Issue for the Modelling of Phenotypes Observed in Alzheimer's Disease.
Hernández D; Rooney LA; Daniszewski M; Gulluyan L; Liang HH; Cook AL; Hewitt AW; Pébay A
Stem Cell Rev Rep; 2022 Feb; 18(2):718-731. PubMed ID: 33725267
[TBL] [Abstract][Full Text] [Related]
15. Modeling Alzheimer's Disease Using Human Brain Organoids.
Karmirian K; Holubiec M; Goto-Silva L; Fernandez Bessone I; Vitória G; Mello B; Alloatti M; Vanderborght B; Falzone TL; Rehen S
Methods Mol Biol; 2023; 2561():135-158. PubMed ID: 36399268
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
[TBL] [Abstract][Full Text] [Related]
17. Human Cytomegalovirus Compromises Development of Cerebral Organoids.
Brown RM; Rana PSJB; Jaeger HK; O'Dowd JM; Balemba OB; Fortunato EA
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217239
[TBL] [Abstract][Full Text] [Related]
18. Intranasal administration of induced pluripotent stem cell-derived cortical neural stem cell-secretome as a treatment option for Alzheimer's disease.
Mo H; Kim J; Kim JY; Kim JW; Han H; Choi SH; Rim YA; Ju JH
Transl Neurodegener; 2023 Nov; 12(1):50. PubMed ID: 37946307
[TBL] [Abstract][Full Text] [Related]
19. Harnessing cerebral organoids for Alzheimer's disease research.
Bubnys A; Tsai LH
Curr Opin Neurobiol; 2022 Feb; 72():120-130. PubMed ID: 34818608
[TBL] [Abstract][Full Text] [Related]
20. Modelling neurodegenerative disease using brain organoids.
Wray S
Semin Cell Dev Biol; 2021 Mar; 111():60-66. PubMed ID: 32513498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
